Chronix 20team 20oellerich 20schuetz 20beck 20hbu 20img 0926s

Chronix Biomedical

Chronix Biomedical has signed up two major customers to buy its cancer testing service and looking for capital to expand sales and marketing.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location San Jose, CA, USA
  • Currency USD
  • Founded August 1997
  • Employees 13
  • Incorporation Type Other
  • Website

Company Summary

Chronix Biomedical is the leading pioneer in liquid biopsies for cancer and organ transplant integrity. The Company has signed contracts with two major cancer centers to purchase a combination of one-of-a-kind cancer diagnostic tests that can 1) predict treatment outcomes and 2) monitor disease status with a blood liquid biopsy. Chronix Biomedical is expanding its sales and marketing efforts world-wide.


  • Default avatar
    Howard Urnovitz

    Howard Urnovitz has over 30 years experience in innovative medical diagnostics. He founded Calypte Biomedical where he obtained 2 FDA approvals for the only approved urine HIV tests, launched the tests in the US and China, led successful financings including an IPO, negotiated partnerships and licensing deals. He co-founded Chronix Biomedical to provide breakthrough genetic tests through certified labs that can monitor and screen for all cancers.

  • Default avatar
    John DiPietro
    Chief Financial Officer

    John DiPietro has over 30 years in finance experience in technology firms. He managed 3 IPOs and raised over $200 million in public and private equity and debt deals. He is former CFO/COO at Calypte Biomedical, Meris Labs and Tripath. He received his MBA at the University of Chicago.

  • Default avatar
    Ekkehard Schütz
    Chief Technology Officer

    Professor Dr. Ekkehard Schütz has over 25 years experience in research and development of medical diagnostics. He has published over 120 peer-reviewed publications, over 100 abstracts, reviews and book chapters and the recipient of several scientific awards in molecular diagnostics and clinical chemistry. He received his MD and PhD at the University of Göttingen in Germany where he also achieved the status of Professor.